Zhang, Kaiqi
Xu, Yuan
Chang, Xusheng
Xu, Caili
Xue, Wenjing
Ding, Dan
Nie, Mingming
Cai, Hui
Xu, Jun
Zhan, Lu
Han, Jiangbo
Cai, Tiancai
Ju, Dianwen
Feng, Li
Zhang, Xuyao
Yin, Kai
Funding for this research was provided by:
National Key Research and Development Program of China (2023YFC3404000, 2023YFC3606600)
National Natural Science Foundation of China (82371781, 32200745)
Shanghai Sailing Program (21YF1401900)
Medical Innovation Research Program of Science and Technology Commission of Shanghai Municipality (21Y11913100)
Article History
Received: 2 December 2023
Accepted: 1 March 2024
First Online: 27 March 2024
Declarations
:
: The other authors declare no conflicts of interest.
: The studies involving human participants were reviewed and approved by the Clinical Research Ethics Committee of Changhai Hospital (CREC: CHEC-2021-119). All procedures followed were per the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. All patients provided their written informed consent to participate in this study. The animal study was reviewed and approved by the Animal Ethical Committee of the School of Pharmacy at Fudan University (AEC: 2020-12-SY-ZXY-01). All institutional and national guidelines for the care and use of laboratory animals were followed.